Fig. 1 · Structure

Documents & Downloads

APN-PEG5-VC-PAB-MMAE

Drug-Linker Conjugate

APN-PEG5-VC-PAB-MMAE is a drug-linker conjugate designed for targeted delivery in cancer therapy, specifically targeting CD71. This compound utilizes a valine-citrulline linkage to release the cytotoxic agent MMAE upon internalization, providing an effective approach to enhance therapeutic efficacy while minimizing systemic toxicity. Its application includes research into antibody-drug conjugates and cancer treatment strategies, particularly in optimizing delivery mechanisms to tumor sites.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer Adooq Bioscience
CAS Number 2252392-31-5
Applications Drug-Linker Conjugate
Formula C81H120N14O18
Molecular Weight 1577.90
SMILES
O[C@@H](C1=CC=CC=C1)[C@@H](C)NC([C@H](C)[C@H]([C@@]2([H])N(CCC2)C(C[C@@H](OC)[C@H]([C@@H](C)CC)N(C)C([C@H](C(C)C)NC([C@H](C(C)C)N(C)C(OCC3=CC=C(C=C3)NC([C@@H](NC([C@@H](NC(CCOCCOCCOCCOCCOCC(N=N4)=CN4C5=CC=C(C#CC#N)C=C5)=O)C(C)C)=O)CCCNC(N)=O)=O)=O)=O)=O)=O)OC)=O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...